EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY 4.0

Effect of First‐Line Chemotherapy Alone Versus First‐Line Chemotherapy Plus Radiotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer in the IMRT Era: A Retrospective Cohort Study

Zihao Liu iD, Yaru Tian iD, Ji Ma iD, Dong-Fang Meng iD

Cancer Reports · 2026

DOI: 10.1002/cnr2.70531 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Reports, 2026. Verfasst von Zihao Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sci…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Radiotherapy, Intensity-Modulated, Antineoplastic Combined Chemotherapy Protocols, Chemoradiotherapy. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of intensity‐modulated radiotherapy (IMRT) and novel combination chemotherapy regimens in locally advanced pancreatic cancer (LAPC) remains unclear. In this study, we focused on comparing survival between first‐line chemotherapy alone and first‐line chemotherapy plus IMRT in patients with LAPC.

Methods

A total of 70 patients from Shandong Cancer Hospital and Institute were enrolled. The primary endpoint was progression‐free survival (PFS). Survival outcomes were estimated by the Kaplan–Meier method and compared by the log‐rank test, and the multivariate Cox proportional hazards model was used to estimate hazard ratios (HRs), 95% CIs, and independent prognostic factors.

Results

The median PFS was 10.0 months in the chemotherapy alone group and 14.0 months in the chemotherapy plus IMRT group ( p = 0.465). Patients who received chemotherapy alone had a median OS of 12.0 versus 21.0 months for patients who received chemotherapy plus IMRT ( p = 0.156). The chemotherapy alone group had a disease control rate (DCR) of 33.33% (6 of 18), while the chemotherapy plus IMRT group had a DCR of 61.54% (32 of 52) ( p = 0.038). The multivariate Cox regression model was used to adjust for potential prognostic factors. Shorter PFS was observed in men ( p = 0.042), and those with a high serum level of CA 19‐9 ( p = 0.047). Similarly, shorter OS was significantly associated with men ( p = 0.010) and a high serum level of CA 19‐9 ( p = 0.020). Grade 3–4 fatigue or asthenia, decreased appetite, neutrophil count decreased, AST increased, and ALT increased were predominant in the chemotherapy alone group.

Conclusion

The combination of first‐line chemotherapy and IMRT improves the DCR rate ( p = 0.038) and was well tolerated. However, first‐line chemotherapy plus IMRT had no significant difference in PFS ( p = 0.465) and OS ( p = 0.156) compared with chemotherapy alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsRadiotherapy, Intensity-ModulatedAntineoplastic Combined Chemotherapy ProtocolsChemoradiotherapyHumansMaleRetrospective StudiesFemaleMiddle AgedAgedProgression-Free SurvivalPrognosisKaplan-Meier EstimateAdult

Stichwörter der Autor:innen

IMRTchemoradiotherapychemotherapylocally advanced pancreatic cancersurvival outcomes

Autor:innen und Institutionen

  • Department of Interventional Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, P. R. China.
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, P. R. China.
  • Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong L…

ORCID-Profile: Zihao Liu, Yaru Tian, Ji Ma, Dong-Fang Meng

Förderung

  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Liu, Z., Tian, Y., Ma, J., & Meng, D. F. (2026). Effect of First‐Line Chemotherapy Alone Versus First‐Line Chemotherapy Plus Radiotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer in the IMRT Era: A Retrospective Cohort Study. Cancer Reports. https://doi.org/10.1002/cnr2.70531

Vancouver

Liu Z, Tian Y, Ma J, Meng DF. Effect of First‐Line Chemotherapy Alone Versus First‐Line Chemotherapy Plus Radiotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer in the IMRT Era: A Retrospective Cohort Study. Cancer Reports. 2026. doi:10.1002/cnr2.70531

BibTeX
@article{Liu2026,
  author = {Liu, Zihao and Tian, Yaru and Ma, Ji and Meng, Dong-Fang},
  title = {Effect of First‐Line Chemotherapy Alone Versus First‐Line Chemotherapy Plus Radiotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer in the IMRT Era: A Retrospective Cohort Study},
  journal = {Cancer Reports},
  year = {2026},
  doi = {10.1002/cnr2.70531}
}
Kostenlos starten →